HanchorBio Presents Preclinical Data on HCB301 at SITC 2025
HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD - L1, and TGFβ; it shows potent macrophage activation, T-cell restoration, and tumor microenvironment remodeling in preclinical solid tumor models. TAIPEI, SHANGHAI,...
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic platform-based collaboration with Eli Lilly and...
SingHealth Duke-NUS Launches Two New Global Health Centres to Advance Allied Health and Pharmacy Practices in Asia
The Centre for Global Allied Health and Centre for Global Pharmacy will advance global health collaboration and capacity building, with a focus on strengthening allied health and pharmacy practices across Asia. Both centres build on a legacy of more...
Xinhua Silk Road: Fujian's Nanping and Fuzhou deepen "mountain-sea cooperation" for shared development
BEIJING, Nov. 5, 2025 /PRNewswire/ -- The photo shows the exterior view of the "Wuyi Landscape" agricultural and speciality products exhibition center in Fuzhou, southeast China's Fujian Province. The photo shows the exterior view of the "Wuyi...
Google and Dot Inc. Unite in a Strategic Partnership to Make Education More Inclusive
Google and Korean startup Dot Inc. have joined forces to advance education for blind and low-vision learners worldwide. SEOUL, South Korea, Nov. 4, 2025 /PRNewswire/ -- Google Asia Pacific and Dot Inc. have signed a strategic Memorandum of...
RSPO, NASH and ASB United Join Forces to Empower Malaysia's Smallholders and Advance Sustainable Palm Oil
KUALA LUMPUR, Malaysia, Nov. 4, 2025 /PRNewswire/ -- The Roundtable on Sustainable Palm Oil (RSPO), Asia School of Business (ASB) through its Center for Sustainable Small-owners (CSS), and National Association of Smallholders (NASH), have signed a...
ECARX Secured up to $150 Million to Advance Strategic Growth Initiatives and Strengthen Liquidity
LONDON, Nov. 1, 2025 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility technology provider, today announced that it had entered into a securities purchase agreement (the "Transaction") with ATW Partners,...
JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an Amendment...
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
Everest Medicines acquired an exclusive license to develop, manufacture, and commercialize VIS-101 in Greater China, Singapore, South Korea, and certain Southeast Asian countries. Under the assigned exclusive license, Everest Medicines will make an...
ARBOR Technology, Datature, and MemryX Partner to Advance Vision AI at the Edge
TAIPEI, Oct. 29, 2025 /PRNewswire/ -- ARBOR Technology Corp., a global leader in industrial IoT and edge AI computing solutions, together with Datature, an innovator in no-code Vision AI platforms, and MemryX, a pioneer in AI accelerator chips,...